NSC
65
5
RF
66
2
EXPD
53
8
PNC
67
3
CNP
65
2
DHI
56
8
NWS
64
2
BEN
50
4
HUM
43
-6
CLX
68
-3
JNPR
50
4
CI
55
3
CFG
68
-2
HCP
70
2
AKAM
53
2
KO
49
5
EW
43
4
HD
61
4
CHD
48
-6
LUV
45
5
NSC
65
5
RF
66
2
EXPD
53
8
PNC
67
3
CNP
65
2
DHI
56
8
NWS
64
2
BEN
50
4
HUM
43
-6
CLX
68
-3
JNPR
50
4
CI
55
3
CFG
68
-2
HCP
70
2
AKAM
53
2
KO
49
5
EW
43
4
HD
61
4
CHD
48
-6
LUV
45
5
Financhill
Back

OptimizeRx 10K Form

Sell
22

OPRX
OptimizeRx

Last Price:
4.98
Seasonality Move:
11.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-05 10Q OPRX/OptimizeRx Quarterly
2020-05-06 10Q OPRX/OptimizeRx Quarterly
2020-03-26 10K OPRX/OptimizeRx Annual
2019-11-05 10Q OPRX/OptimizeRx Quarterly
2019-08-07 10Q OPRX/OptimizeRx Quarterly
2019-05-08 10Q OPRX/OptimizeRx Quarterly

Receive OPRX News And Ratings

See the #1 stock for the next 7 days that we like better than OPRX

OPRX Financial Statistics

Sales & Book Value

Annual Sales: $71.52M
Cash Flow: $1.7M
Price / Cash Flow: 0
Annual Sales: $6.25
Price / Book: 0.75

Profitability

EPS (TTM): -1.34000
Net Income (TTM): $-24.17M
Gross Margin: $42.9M
Return on Equity: -20.12%
Return on Assets: -14.71%

OptimizeRx Earnings Forecast

Key OptimizeRx Financial Ratios

  • The Gross Profit Margin over the past 17 years for OPRX is 59.98%.
  • The Selling, General & Administrative Expenses for OPRX have been equal to 81.12% of Gross Profit Margin.
  • The Research & Development expenses have been 2.49% of Revenue.
  • The Interest Expense is -8.28% of Operating Income.
  • The Net Earning history of OPRX is -24.56% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 7 years.

OptimizeRx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: OPRX
CUSIP: 68401U
Website: optimizerx.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 3.23
Quick Ratio: 2.93

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 13.24

OPRX Technical Analysis vs Fundamental Analysis

Sell
22
OptimizeRx (OPRX) is a Sell

Is OptimizeRx a Buy or a Sell?

  • OptimizeRx stock is rated a Sell
    The current OptimizeRx [OPRX] share price is $4.65. The Score for OPRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.